189 related articles for article (PubMed ID: 6702418)
21. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
22. Activation of the alternative complement pathway by unidentified substances in human glomerulonephritis.
Schena FP; Pertosa G; Vox E; Bonomo L
Nephron; 1981; 27(1):9-14. PubMed ID: 6908651
[TBL] [Abstract][Full Text] [Related]
23. [Immune complex and complement levels in spontaneous abortions and normal pregnancy].
Saitoh S; Nakanishi A; Ichijo M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1981-90. PubMed ID: 6607297
[TBL] [Abstract][Full Text] [Related]
24. [Immune complexes and complement in leprosy (author's transl)].
Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
[TBL] [Abstract][Full Text] [Related]
25. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
26. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Annunziata P; Volpi N
Acta Neurol Scand; 1985 Jul; 72(1):61-4. PubMed ID: 4050318
[TBL] [Abstract][Full Text] [Related]
27. [Complement 3 level in the cerebrospinal fluid in multiple sclerosis].
Wajgt A
Neurol Neurochir Pol; 1980; 14(3):275-82. PubMed ID: 7412984
[TBL] [Abstract][Full Text] [Related]
28. Serum complement (C3, C4) levels in patients with acute myocardial infarction and angina pectoris.
Giasuddin AS; ElMahdawi JM; ElHassadi FM
Bangladesh Med Res Counc Bull; 2007 Dec; 33(3):98-102. PubMed ID: 18783065
[TBL] [Abstract][Full Text] [Related]
29. Characterization of immune complexes in multiple sclerosis by an antigen-specific immune complex radioimmunoassay.
Lund GA; Arnadottir T; Hukkanen V; Reunanen M; Salmi A
J Neuroimmunol; 1983 Jun; 4(3):253-64. PubMed ID: 6853697
[TBL] [Abstract][Full Text] [Related]
30. Immune complexes in retinitis pigmentosa.
Heredia CD; Huguet J; Cols N; Engel P; García-Calderón PA
Br J Ophthalmol; 1984 Nov; 68(11):811-4. PubMed ID: 6333894
[TBL] [Abstract][Full Text] [Related]
31. Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.
Richens ER; Thorp CM; Bland PW; Hall ND
Dig Dis Sci; 1982 Feb; 27(2):129-38. PubMed ID: 7075407
[TBL] [Abstract][Full Text] [Related]
32. Circulating immune complexes, complement activation kinetics and serum sickness following treatment with heterologous anti-snake venom globulin.
Nielsen H; Sørensen H; Faber V; Svehag SE
Scand J Immunol; 1978; 7(1):25-33. PubMed ID: 635471
[TBL] [Abstract][Full Text] [Related]
33. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
34. Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
Lindblom RP; Aeinehband S; Ström M; Al Nimer F; Sandholm K; Khademi M; Nilsson B; Piehl F; Ekdahl KN
Clin Immunol; 2016 May; 166-167():89-95. PubMed ID: 27085202
[TBL] [Abstract][Full Text] [Related]
35. Circulating immune complexes and complement levels in hemophilic children.
Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
[TBL] [Abstract][Full Text] [Related]
36. Human serum induced opsonization of immunoglobulin G-coated polystyrene microspheres with complement components C3 and C4 as measured by flow cytometry.
Spycher MO; Spycher-Burger M; Späth PJ; Burckhardt JJ
J Immunol Methods; 1991 Dec; 145(1-2):83-92. PubMed ID: 1765669
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
38. Circulating and deposited immune complexes in patients with glomerular disease: immunopathologic correlations.
Stachura I; Whiteside TL; Kelly RH
Am J Pathol; 1981 Apr; 103(1):21-30. PubMed ID: 6908818
[TBL] [Abstract][Full Text] [Related]
39. Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.
Aeinehband S; Lindblom RP; Al Nimer F; Vijayaraghavan S; Sandholm K; Khademi M; Olsson T; Nilsson B; Ekdahl KN; Darreh-Shori T; Piehl F
PLoS One; 2015; 10(4):e0122048. PubMed ID: 25835709
[TBL] [Abstract][Full Text] [Related]
40. Diffuse CNS involvement in systemic lupus erythematosus: intrathecal synthesis of the 4th component of complement.
Jongen PJ; Boerbooms AM; Lamers KJ; Raes BC; Vierwinden G
Neurology; 1990 Oct; 40(10):1593-6. PubMed ID: 2215952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
